| Profile | GDS1873 / 214499_s_at |
| Title | Antiestrogen and aromatase inhibitor effect on breast cancer cells |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM40787 | control - Rep 1 | 271.346 | 62 |
| GSM40788 | control - Rep 2 | 231.414 | 58 |
| GSM40789 | control - Rep 3 | 212.294 | 55 |
| GSM40775 | androgen treated - Rep 1 | 221.214 | 57 |
| GSM40776 | androgen treated - Rep 2 | 199.545 | 54 |
| GSM40777 | androgen treated - Rep 3 | 209.986 | 55 |
| GSM40790 | estrogen treated - Rep 1 | 240.185 | 59 |
| GSM40791 | estrogen treated - Rep 2 | 253.64 | 60 |
| GSM40792 | estrogen treated - Rep 3 | 243.143 | 59 |
| GSM40784 | A + tamoxifen - Rep 1 | 245.839 | 60 |
| GSM40785 | A + tamoxifen - Rep 2 | 202.953 | 54 |
| GSM40786 | A + tamoxifen - Rep 3 | 217.615 | 56 |
| GSM40778 | A + anastrozole - Rep 1 | 204.477 | 54 |
| GSM40779 | A + anastrozole - Rep 2 | 310.96 | 65 |
| GSM40780 | A + anastrozole - Rep 3 | 230.992 | 58 |
| GSM40781 | A + letrozole - Rep 1 | 166.343 | 47 |
| GSM40782 | A + letrozole - Rep 2 | 290.029 | 64 |
| GSM40783 | A + letrozole - Rep 3 | 232.014 | 58 |